Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2026-05-26 @ 5:48 PM
Study NCT ID:
NCT01521767
Status:
COMPLETED
Last Update Posted:
2021-01-27
First Post:
2012-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacokinetics and Relative Bioavailability Study
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A6121196
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None